Page 6 - Forefront Analytics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cantor Fitzgerald Investment Advisors L.P. purchased a new stake in shares of iShares Floating Rate Bond ETF (BATS:FLOT – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 7,438 shares of the company’s stock, valued at approximately $377,000. A number of other hedge funds and other institutional investors also recently added to […]

Zura Bio Limited (NASDAQ:ZURA – Get Free Report) Director Van Amstel Arnout Ploos acquired 80,000 shares of the firm’s stock in a transaction that occurred on Friday, May 17th. The shares were bought at an average price of $6.20 per share, with a total value of $496,000.00. Following the acquisition, the director now directly owns […]

Annexon, Inc. (NASDAQ:ANNX – Get Free Report) has been given an average rating of “Buy” by the six analysts that are covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1 year target price among analysts that have issued a report on the stock in the […]

Shares of Annexon, Inc. (NASDAQ:ANNX – Get Free Report) have been given a consensus rating of “Buy” by the six brokerages that are presently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have updated their coverage on the […]

JMP Securities reaffirmed their market outperform rating on shares of Athira Pharma (NASDAQ:ATHA – Free Report) in a research note released on Thursday morning, Benzinga reports. JMP Securities currently has a $19.00 price objective on the stock. Athira Pharma Price Performance Shares of ATHA stock opened at $2.52 on Thursday. Athira Pharma has a 1 […]